ETC-1002
1002-006
Phase 3 small_molecule completed
Quick answer
ETC-1002 for Hypercholesterolemia is a Phase 3 program (small_molecule) at Esperion Therapeutics with 6 ClinicalTrials.gov record(s).
Program details
- Company
- Esperion Therapeutics
- Indication
- Hypercholesterolemia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed